FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Onyx Biotec IPO and Rosmerta Digital Services IPO.
Onyx Biotec IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Rosmerta Digital Services IPO is a SME Book Built Issue proposed to list at BSE SME.
Onyx Biotec IPO | Rosmerta Digital Services IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | NSE SME | BSE SME |
Lead Managers | Horizon Management Private Limited | Narnolia Financial Services Ltd Beeline Capital Advisors Pvt Ltd |
Registrar | Mas Services Limited | Link Intime India Private Ltd |
Market Maker | Giriraj Stock Broking Private Limited | Spread X Securities Private Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | |
IPO Allotment URL |
The total issue size of Onyx Biotec IPO is up to ₹29.34 Cr whereas the issue size of the Rosmerta Digital Services IPO is up to ₹206.33 Cr. The final issue price of Onyx Biotec IPO is and of Rosmerta Digital Services IPO is .
Onyx Biotec IPO | Rosmerta Digital Services IPO | |
---|---|---|
Face Value | ₹10 per share | ₹2 per share |
Issue Price (Lower) | ₹58.00 per share | ₹140.00 per share |
Issue Price (Upper) | ₹61.00 per share | ₹147.00 per share |
Issue Price (Final) | ||
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 2000 shares | 1000 shares |
Fresh Issue Size | 48,10,000 shares | 1,40,36,000 shares |
Fresh Issue Size (Amount) | up to ₹29.34 Cr | up to ₹206.33 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 48,10,000 shares | 1,40,36,000 shares |
Issue Size Total (Amount) | up to ₹29.34 Cr | up to ₹206.33 Cr |
Onyx Biotec IPO opens on Nov 13, 2024, while Rosmerta Digital Services IPO opens on Nov 18, 2024. The closing date of Onyx Biotec IPO and Rosmerta Digital Services IPO is Nov 18, 2024, and Nov 21, 2024, respectively.
Onyx Biotec IPO | Rosmerta Digital Services IPO | |
---|---|---|
Anchor Bid Date | Nov 12, 2024 | Nov 14, 2024 |
Issue Open | Nov 13, 2024 | Nov 18, 2024 |
Issue Close | Nov 18, 2024 | Nov 21, 2024 |
Basis Of Allotment (Tentative) | Nov 19, 2024 | Nov 22, 2024 |
Initiation of Refunds (Tentative) | Nov 20, 2024 | Nov 25, 2024 |
Credit of Share (Tentative) | Nov 20, 2024 | Nov 25, 2024 |
Listing date (Tentative) | Nov 21, 2024 | Nov 26, 2024 |
Anchor Lockin End date 1 | Dec 19, 2024 | Dec 22, 2024 |
Anchor Lockin End date 2 | Feb 17, 2025 | Feb 20, 2025 |
Onyx Biotec IPO P/E ratio is 26.81, as compared to Rosmerta Digital Services IPO P/E ratio of 54.33.
Onyx Biotec IPO | Rosmerta Digital Services IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Onyx Biotec Limited Financial Information (Restated)Onyx Biotec Limited's revenue increased by 35.99% and profit after tax (PAT) rose by 64.35% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Rosmerta Digital Services Limited Financial Information (Restated)Rosmerta Digital Services Limited's revenue increased by 183% and profit after tax (PAT) rose by 553% between the financial year ending with March 31, 2024 and March 31, 2023.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 88.60% | 89.74% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 66.02% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 26.81 | 54.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹110.61 Cr. | ₹780.36 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 4.99%% | 0.36%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 3.71%% | 0.28%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 1.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹2.28 | ₹2.71 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 4.99%% | 20.72%% |
In the Onyx Biotec IPO retail investors (RII) are offered while in Rosmerta Digital Services IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Onyx Biotec IPO and in Rosmerta Digital Services IPO.
Onyx Biotec IPO | Rosmerta Digital Services IPO | |
---|---|---|
Anchor Investor Reserveration | 13,66,000 shares | 39,98,000 shares |
Market Maker Reserveration | 2,44,000 shares | 7,03,000 shares |
QIB | ||
NII | ||
RII | ||
Employee | ||
Others | ||
Total |
Onyx Biotec IPO subscribed in total, whereas Rosmerta Digital Services IPO subscribed .
Onyx Biotec IPO | Rosmerta Digital Services IPO | |
---|---|---|
QIB (times) | ||
NII (times) | ||
Big NII (times) | ||
Small NII (times) | ||
RII (times) | ||
Employee (times) | ||
Other (times) | ||
Total (times) |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|